All journal publications
Filters: term is internal publication [Clear All Filters]
- 2011
Advances in paediatric pharmacokinetics,
Expert Opin Drug Metab Toxicol, vol. 7, no. 1, pp. 1-8. DOI
- 2010
Effect of altered AGP plasma binding on heart rate changes by S(-)-propranolol in rats using mechanism-based estimations of in vivo receptor affinity (K(B,vivo)),
J Pharm Sci, vol. 99, no. 5, pp. 2511-20. DOI
The role of population PK-PD modelling in paediatric clinical research,
Eur J Clin Pharmacol. DOI
A model-based approach to dose selection in early pediatric development,
Clin Pharmacol Ther, vol. 87, no. 3, pp. 294-302. DOI
Predictive performance of a recently developed population pharmacokinetic model for morphine and its metabolites in new datasets of (preterm) neonates, infants and children,
Clin Pharmacokinet, vol. 50, no. 1, pp. 51-63. DOI
Online solid phase extraction with liquid chromatography-tandem mass spectrometry to analyze remoxipride in small plasma-, brain homogenate-, and brain microdialysate samples,
J Chromatogr B Analyt Technol Biomed Life Sci, vol. 878, no. 13-14, pp. 969-75. DOI
Prediction of propofol clearance in children from an allometric model developed in rats, children and adults versus a 0.75 fixed-exponent allometric model,
Clin Pharmacokinet, vol. 49, no. 4, pp. 269-75. DOI
- 2009
From trial and error to trial simulation. Part 1: the importance of model-based drug development for antidepressant drugs,
Clin Pharmacol Ther, vol. 86, no. 3, pp. 248-54. DOI
From trial and error to trial simulation. Part 2: an appraisal of current beliefs in the design and analysis of clinical trials for antidepressant drugs,
Clin Pharmacol Ther, vol. 86, no. 3, pp. 255-62. DOI
Prediction of antiepileptic drug efficacy: the use of intracerebral microdialysis to monitor biophase concentrations,
Expert Opin Drug Metab Toxicol, vol. 5, no. 10, pp. 1267-77. DOI
Differences in the sensitivity of behavioural measures of pain to the selectivity of cyclo-oxygenase inhibitors,
Eur J Pain, vol. 13, no. 5, pp. 448-57. DOI
Differential receptor-mediated drug targeting to the diseased brain,
Expert Opin Drug Deliv, vol. 6, no. 3, pp. 227-37. DOI
Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling,
Drug Discov Today, vol. 14, no. 5-6, pp. 316-20. DOI
Functional characterization of excision repair and RecA-dependent recombinational DNA repair in Campylobacter jejuni,
J Bacteriol, vol. 191, no. 12, pp. 3785-93. DOI
Commentary: "A systems view on the future of medicine: inspiration from Chinese medicine?",
J Ethnopharmacol, vol. 121, no. 3, pp. 479-81. DOI
Changes in GABAA receptor properties in amygdala kindled animals: in vivo studies using [11C]flumazenil and positron emission tomography,
Epilepsia, vol. 50, no. 1, pp. 88-98. DOI
Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex,
Anesthesiology, vol. 110, no. 1, pp. 95-105. DOI
Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex,
Anesthesiology, vol. 110, no. 1, pp. 95-105. DOI
Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematologic stem cell transplantation,
Biol Blood Marrow Transplant, vol. 15, no. 2, pp. 231-41. DOI


